A. Langlois et al., RESPONSE HETEROGENEITY OF 5-HT3 RECEPTOR ANTAGONISTS IN A RAT VISCERAL HYPERSENSITIVITY MODEL, European journal of pharmacology, 318(1), 1996, pp. 141-144
Subcutaneous administration of granisetron (BRL 43694, abicyclo[3.3.1]
non-3-yl-1H-indazole-3-carboxamide) and zacopride clo[2.2.2.]oct-3-yl)
-5-chloro-2-methoxybenzamide), two 5-HT3 receptor antagonists, at dose
s ranging from 3 to 1000 mu g/kg, inhibited abdominal contractions ind
uced by distension (30 mmHg, 10 min) of irritated colon (0.6% acetic a
cid) in conscious rats with a bell-shaped dose-response curve. The ED(
50) of granisetron and zacopride were 17.6 and 8.2 mu g/kg, respective
ly, In contrast, both tropisetron (ICS 205-930, (3-a-tropanyl)1-indole
-3-carboxylic ester) and ondansetron (GR38032F, -methyl-1H-imidazol-1-
yl)methyl]-4H-carbazol-4-one hydrocloride dihydrate) were inactive in
this model. These data further support the concept of a heterogeneity
in the potency of 5-HT3 receptor antagonists in modulating visceral hy
persensitivity in conscious rats. This finding is in agreement with a
reported efficacy of granisetron but not of ondansetron in patients wi
th irritable bowel syndrome.